Clinical Trial Update: Study to Demonstrate the Bioequivalence of the Fixed Dose Combination of COREG CR™ and Lisinopril to Its Components [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated whether the fixed-dose combination of COREG CR and Lisinopril is bioequivalent to taking the two components separately in hypertension…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• COREG CR (carvedilol phosphate)
• Lisinopril (Lisinopril)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hypertension | Phase 1 | Status: COMPLETED